Umlaut.bio is a Heidelberg biotechnology company developing small-molecule therapeutics that modulate tRNA modifications to alter protein expression for disease treatment. Bastian Linder and Karsten Fischer founded it in 2024.
Email and phone for Umlaut.bio are available to signed-in members of CliffBio.
Sign in to view